Parkinson's UK selected as charity partner of Annapurna Recruitment
We’re pleased to announce a new charity partnership with Annapurna Recruitment.
Why Ohsumi's Nobel Prize is important for Parkinson's
The 2016 Nobel Prize has been awarded to Yoshinori Ohsumi for his work on how cells dispose of and recycle waste – a process linked to Parkinson's.
Study finds caffeine compounds to tackle Parkinson's
New research published in the journal ACS Chemical Neuroscience has identified caffeine-like compounds that may tackle the underlying causes of Parkinson's.
Parkinson's UK welcomes benefit announcement
Work and Pensions Secretary, Damian Green, announced today, Saturday 1 October, that people with long-term health conditions will be exempt from Employment and Support Allowance (ESA) reassessment.
Parkinson's UK wins prestigious Charity Times award
Parkinson's UK was named 'Change Project of the Year' winner at the prestigious Charity Times Awards on Wednesday 28 September.
Odour study from Parkinson's UK features on BBC2 programme
BBC Two programme 'Nature's Weirdest Events' will feature a Parkinson's UK study into whether skin odour can lead to early diagnosis of Parkinson's.
New research highlights importance of cardiovascular health in Parkinson's
New research shows that people recently diagnosed with Parkinson's who are at high or medium risk of cardiovascular disease tend to have more problems with walking and memory.
New report calls for better neurological care
A new report that investigates issues with how people with neurological conditions are diagnosed and referred to specialists has been released.
Study shows potential benefit for caffeine in Parkinson's
A new clinical study published in the journal Parkinsonism and Related Disorders links higher caffeine consumption to slower development of Parkinson's symptoms after diagnosis.
Parkinson's UK at the World Parkinson Congress this week
Parkinson's UK is at the World Parkinson Congress 2016 in Portland, Oregon to share experiences and learn about the latest Parkinson's research and thinking.